Antiepileptic effects of ghrelin on pentylenetetrazole-induced seizures in rats.
It is well known that neuropeptide Y (NPY) and gamma-aminobutyric acid (GABA) exert antiepileptic effects in animal models. It has recently been shown that ghrelin neurons increase the activities of GABA and NPY in the brain. Therefore it can be said that ghrelin is an antiepileptic agent. In this study we aimed to investigate the antiepileptic effect of ghrelin in an acute experimental epilepsy model in pentylenetetrazole (PTZ) injected rats. Adult male Wistar albino rats were divided into a control group and four experimental groups with seven rats in each group. In order to generate epileptic seizures, PTZ (50mg/kg) was injected intraperitoneally. The experimental groups received intraperitoneal injections of ghrelin at doses of 20, 40, 60 and 80microg/kg 30min before PTZ injection. After PTZ injection, the latencies were separated into three components: first myoclonic jerk, generalized clonic seizures and tonic generalized extension. The injection of 50mg/kg PTZ-induced epileptic seizures in the control group. The onset times of the three characteristic behavioral changes were significantly delayed and the duration of tonic generalized extension was diminished by dose-dependent ghrelin administration. Our results demonstrated that ghrelin suppresses the onset time of PTZ-induced seizures. In the light of our current knowledge, it seems that ghrelin may be considered as an antiepileptic drug.
Obay
Basra Deniz
BD
Dicle University Faculty of Medicine, Department of Physiology, 21280 Diyarbakir, Turkey. bobay@dicle.edu.tr
Tasdemir
Ezel
E
Tümer
Cemil
C
Bilgin
Hakki Murat
HM
Sermet
Abdurrahman
A
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D003292:Convulsants / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D054439:Ghrelin; D007274:Injections, Intraperitoneal; D008297:Male; D010433:Pentylenetetrazole / Q000494:pharmacology*; D036361:Peptide Hormones / Q000494:pharmacology* / Q000627:therapeutic use; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D012640:Seizures / Q000188:drug therapy*; D013997:Time Factors
D000927:Anticonvulsants; D003292:Convulsants; D054439:Ghrelin; D036361:Peptide Hormones; D010433:Pentylenetetrazole